LAUREN LEWIS: Open Payments
NPI 1982139440 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$688 in 29 payments from 16 companies in 2025. Trend: 2023 $418 · 2024 $656 · 2025 $688
Food & beverage: $588Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $269 |
| Eisai Inc. | 3 | $71 |
| PFIZER INC. | 2 | $51 |
| Merck Sharp & Dohme LLC | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $25 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $24 |
| Legend Biotech USA Inc. | 1 | $23 |
| Myriad Genetic Laboratories, Inc. | 1 | $22 |
Products named: ERLEADA, Lenvima, XTANDI, KEYTRUDA, Enhertu, PLUVICTO, PYLARIFY, CARVYKTI.
Industry payments across OK — which companies pay providers there.
